The vaccination campaign got a major boost on Saturday, when the US Food and Drug Administration greenlit Johnson & Johnson’s single-dose coronavirus shot. An FDA review published on Wednesday showed the shot is safe and effective against COVID-19.
J&J’s shot will be the third coronavirus vaccine to be distributed across the US. Vaccines from Pfizer and Moderna have been administered to more than 48 million Americans thus far, though fewer than 24 million Americans have gotten the full two-dose regimen.
Here’s a timeline of how vaccinations could ramp up in the next five months:
- March 31: 240 million doses distributed
- May 31: 420 million doses distributed
- June 30: 500 million doses distributed
- July 31: 700 million doses distributed
End of March: Wrapping up vaccinations for priority groups
J&J originally planned to deliver 12 million doses by the end of February. But federal officials have said that just 3 to 4 million doses would be immediately available next week.
End of May: The general population gets its shots
Both companies are also still trying to speed up their vaccine rollouts.
End of June: All adults could have access to a shot
Federal officials still hope J&J can speed up that timeline.
End of July: The US could have a surplus of doses
By the end of July, the US could have more vaccines than it’s able to distribute.
This article was updated on February 27 with FDA’s decision to issue an emergency use authorization for J&J’s vaccine.
Something is loading.